JDRF Blog

JDRF Golf Challenge

The name Garfinkle is synonymous with JDRF Canada. Over 50 years ago, in 1971 and 1973 respectively, Krayna Golfman and Mitch Garfinkle saw their sons, David and Jimmy diagnosed with […]

New Drug to Prevent Hypoglycemia Enters Clinical Trials

Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue treatments for it, such as injectable or nasal glucagon (Baqsimi), there are currently no preventive therapies available. Canadian company Zucara Therapeutics, however, may have an answer.

JDRF 2023 Innovation Grants

JDRF provides seed funding for highly innovative research with significant potential to accelerate the most promising type 1 diabetes (T1D) research in both cures and approaches to improve disease management. […]

Meet our new Board Chair – Helena Gottschling

In late April 2023, Helena Gottschling was elected Board Chair for JDRF Canada. Helena Gottschling is a purpose-driven leader who enjoyed a 37-year career with RBC before retiring in 2022. […]

JDRF-CIHR Mental Health Grants

Mental health and psychosocial issues remain an under-researched yet frequent aspect of living with type 1 diabetes (T1D). As part of the JDRF-CIHR Partnership to Defeat Diabetes, JDRF is pleased […]

Mental Health and Diabetes – where JDRF is today

May is Mental Health Awareness month, a national movement to raise awareness of the importance of mental health, and the structural gaps that exist in accessing treatment and support. There […]

Clinical Trials

In addition to funding critical type 1 diabetes (T1D) clinical trials, a key focus for JDRF is increasing awareness of and participation in trials. All new interventions, from drugs to […]

Stay connected on the latest

  •  

Help Us Create a World Without Type 1 Diabetes

Give Now